The toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4249-4260

  Noris, Marina ^a   Cassis, Paola ^a   Azzollini, Nadia ^a   Cavinato, Regiane ^a   Cugini, Daniela ^a   Casiraghi, Federica ^a   Aiello, Sistiana ^a   Solini, Samantha ^a   Cassis, Linda ^a   Mister, Marilena ^a   Todeschini, Marta ^a   Abbate, Mauro ^a   Benigni, Ariela ^a   Trionfini, Piera ^a   Tomasoni, Susanna ^a   Mele, Caterina ^a   Garlanda, Cecilia ^c   Polentarutti, Nadia ^c   Mantovani, Alberto ^c,d   Remuzzi, Giuseppe ^a,b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b MARIO NEGRI INST PHARMACOL RES   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; PROTEIN; PROTEIN TIR8; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; MEMBRANE PROTEIN; TIR8 PROTEIN, MOUSE; TIRAP PROTEIN, MOUSE;

ACUTE GRAFT REJECTION; ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE SEVERITY; GENE DELETION; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; MALE; MOUSE; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; STEM CELL EXPANSION; ACUTE DISEASE; ANIMAL; C57BL MOUSE; CBA MOUSE; DBA MOUSE; DISEASE MODEL; DOWN REGULATION; DRUG ANTAGONISM; GENETICS; GRAFT REJECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT; PHYSIOLOGY;

ACUTE DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GRAFT REJECTION; IMMUNE TOLERANCE; KIDNEY TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; MICE, INBRED DBA; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-1; REPERFUSION INJURY;

EID: 70449709584     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803549     Document Type: Article

References (64)

1. Land, W., H. Schneeberger, S. Schleibner, W. D. Illner, D. Abendroth, G. Rutili, K. E. Arfors, and K. Messmer. 1994. The beneficial effect of human recombinant superoxide dismutase on acute and chronic rejection events in recipients of cadaveric renal transplants. Transplantation 57: 211-217.
2. Land, W. G. 2005. The role of postischemic reperfusion injury and other nonantigen-dependent inflammatory pathways in transplantation. Transplantation 79: 505-514.
3. Kim, B. S., S. W. Lim, C. Li, J. S. Kim, B. K. Sun, K. O. Ahn, S. W. Han, J. Kim, and C. W. Yang. 2005. Ischemia-reperfusion injury activates innate immunity in rat kidneys. Transplantation 79: 1370-1377.
4. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2007. Resident dendritic cells are the predominant TNF-secreting cell in early renal ischemia-reperfusion injury. Kidney Int. 71: 619-628.
5. Kaczorowski, D. J., A. Nakao, K. P. Mollen, R. Vallabhaneni, R. Sugimoto, J. Kohmoto, K. Tobita, B. S. Zuckerbraun, K. R. McCurry, N. Murase, and T. R. Billiar. 2007. Toll-like receptor 4 mediates the early inflammatory response after cold ischemia/reperfusion. Transplantation 84: 1279-1287.
6. Haq, M., J. Norman, S. R. Saba, G. Ramirez, and H. Rabb. 1998. Role of IL-1 in renal ischemic reperfusion injury. J. Am. Soc. Nephrol. 9: 614-619. (Pubitemid 28186050)
7. Leemans, J. C., G. Stokman, N. Claessen, K. M. Rouschop, G. J. Teske, C. J. Kirschning, S. Akira, T. van der Poll, J. J. Weening, and S. Florquin. 2005. Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J. Clin. Invest. 115: 2894-2903.
8. Wu, H., G. Chen, K. Wyburn, J. Yin, P. Bertolino, J. Eris, S. Alexander, A. Sharland, and S. Chadban. 2007. TLR4 activation mediates kidney ischemia/reperfusion injury. J. Clin. Invest. 117: 2847-2859. (Pubitemid 47529615)
9. McGettrick, A. F., and L. A. O'Neill. 2004. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol. Immunol. 41: 577-582. (Pubitemid 38824615)
10. Obhrai, J., and D. R. Goldstein. 2006. The role of toll-like receptors in solid organ transplantation. Transplantation 81: 497-502. (Pubitemid 43315951)
11. Dong, X., S. Swaminathan, L. A. Bachman, A. J. Croatt, K. A. Nath, and M. D. Griffin. 2005. Antigen presentation by dendritic cells in renal lymph nodes is linked to systemic and local injury to the kidney. Kidney Int. 68: 1096-1108. (Pubitemid 43246426)
12. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311: 17-58. (Pubitemid 47413194)
13. Andrade, C. F., T. K. Waddell, S. Keshavjee, and M. Liu. 2005. Innate immunity and organ transplantation: the potential role of Toll-like receptors. Am. J. Transplant. 5: 969-975. (Pubitemid 40571244)
14. Goldstein, D. R., B. M. Tesar, S. Akira, and F. G. Lakkis. 2003. Critical role of the Toll-like receptor signal adaptor protein MyD88 in acute allograft rejection. J. Clin. Invest. 111: 1571-1578.
15. Chen, L., T. Wang, P. Zhou, L. Ma, D. Yin, J. Shen, L. Molinero, T. Nozaki, T. Phillips, S. Uematsu, et al. 2006. TLR engagement prevents transplantation tolerance. Am. J. Transplant. 6: 2282-2291.
16. Walker, W. E., I. W. Nasr, G. Camirand, B. M. Tesar, C. J. Booth, and D. R. Goldstein. 2006. Absence of innate MyD88 signaling promotes inducible allograft acceptance. J. Immunol. 177: 5307-5316.
17. Tesar, B. M., J. Zhang, Q. Li, and D. R. Goldstein. 2004. TH1 immune responses to fully MHC mismatched allografts are diminished in the absence of MyD88, a Toll-like receptor signal adaptor protein. Am. J. Transplant. 4: 1429-1439.
18. Alegre, M. L., L. Chen, T. Wang, E. Ahmed, C. R. Wang, and A. Chong. 2009. Antagonistic effect of Toll-like receptor signaling and bacterial infections on transplantation tolerance. Transplantation 87: S77-S79.
19. Liew, F. Y., D. Xu, E. K. Brint, and L. A. O'Neill. 2005. Negative regulation of Toll-like receptor-mediated immune responses. Nat. Rev. Immunol. 5: 446-458.
20. Turnquist, H. R., T. L. Sumpter, A. Tsung, A. F. Zahorchak, A. Nakao, G. J. Nau, F. Y. Liew, D. A. Geller, and A. W. Thomson. 2008. IL-1β-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells. J. Immunol. 181: 62-72.
21. Mantovani, A., M. Locati, N. Polentarutti, A. Vecchi, and C. Garlanda. 2004. Extracellular and intracellular decoys in the tuning of inflammatory cytokines and Toll-like receptors: the new entry TIR8/SIGIRR. J. Leukocyte Biol. 75: 738-742.
22. Wald, D., J. Qin, Z. Zhao, Y. Qian, M. Naramura, L. Tian, J. Towne, J. E. Sims, G. R. Stark, and X. Li. 2003. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling. Nat. Immunol. 4: 920-927.
23. Garlanda, C., F. Riva, N. Polentarutti, C. Buracchi, M. Sironi, M. De Bortoli, M. Muzio, R. Bergottini, E. Scanziani, A. Vecchi, E. Hirsch, and A. Mantovani. 2004. Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc. Natl. Acad. Sci. USA 101: 3522-3526.
24. Xiao, H., M. F. Gulen, J. Qin, J. Yao, K. Bulek, D. Kish, C. Z. Altuntas, D. Wald, C. Ma, H. Zhou, et al. 2007. The Toll-interleukin-1 receptor member SIGIRR regulates colonic epithelial homeostasis, inflammation, and tumorigenesis. Immunity 26: 461-475.
25. Garlanda, C., F. Riva, T. Veliz, N. Polentarutti, F. Pasqualini, E. Radaelli, M. Sironi, M. Nebuloni, E. O. Zorini, E. Scanziani, and A. Mantovani. 2007. Increased susceptibility to colitis-associated cancer of mice lacking TIR8, an inhibitory member of the interleukin-1 receptor family. Cancer Res. 67: 6017-6021.
26. Garlanda, C., D. Di Liberto, A. Vecchi, M. P. La Manna, C. Buracchi, N. Caccamo, A. Salerno, F. Dieli, and A. Mantovani. 2007. Damping excessive inflammation and tissue damage in Mycobacterium tuberculosis infection by Toll IL-1 receptor 8/single Ig IL-1-related receptor, a negative regulator of IL-1/TLR signaling. J. Immunol. 179: 3119-3125.
27. Huang, X., L. D. Hazlett, W. Du, and R. P. Barrett. 2006. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. J. Immunol. 177: 548-556. (Pubitemid 43939168)
28. Lech, M., O. P. Kulkarni, S. Pfeiffer, E. Savarese, A. Krug, C. Garlanda, A. Mantovani, and H. J. Anders. 2008. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J. Exp. Med. 205: 1879-1888.
29. Polentarutti, N., G. P. Rol, M. Muzio, D. Bosisio, M. Camnasio, F. Riva, C. Zoja, A. Benigni, S. Tomasoni, A. Vecchi, et al. 2003. Unique pattern of expression and inhibition of IL-1 signaling by the IL-1 receptor family member TIR8/SIGIRR. Eur. Cytokine Network 14: 211-218.
30. Lech, M., C. Garlanda, A. Mantovani, C. J. Kirschning, D. Schlondorff, and H. J. Anders. 2007. Different roles of TiR8/Sigirr on Toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int. 72: 182-192. (Pubitemid 47067388)
31. Bickerstaff, A. A., J. J. Wang, R. P. Pelletier, and C. G. Orosz. 2001. Murine renal allografts: spontaneous acceptance is associated with regulated T cell-mediated immunity. J. Immunol. 167: 4821-4827.
32. + T cells within renal allografts shows infiltration of tubules mimicking rejection. Am. J. Pathol. 171: 1915-1922.
33. Zhang, Z., L. Zhu, D. Quan, B. Garcia, N. Ozcay, J. Duff, C. Stiller, A. Lazarovits, D. Grant, and R. Zhong. 1996. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 62: 1267-1272. (Pubitemid 27008553)
34. Girlanda, R., and A. D. Kirk. 2007. Frontiers in nephrology: immune tolerance to allografts in humans. J. Am. Soc. Nephrol. 18: 2242-2251.
35. Ansari, M. J., and M. H. Sayegh. 2004. Clinical transplantation tolerance: the promise and challenges. Kidney Int. 65: 1560-1563. (Pubitemid 38591001)
36. Kawai, T., A. B. Cosimi, T. R. Spitzer, N. Tolkoff-Rubin, M. Suthanthiran, S. L. Saidman, J. Shaffer, F. I. Preffer, R. Ding, V. Sharma, et al. 2008. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med. 358: 353-361.
37. Racusen, L. C., K. Solez, R. B. Colvin, S. M. Bonsib, M. C. Castro, T. Cavallo, B. P. Croker, A. J. Demetris, C. B. Drachenberg, A. B. Fogo, et al. 1999. The Banff 97 working classification of renal allograft pathology. Kidney Int. 55: 713-723.
38. Noris, M., M. Todeschini, P. Cassis, F. Pasta, A. Cappellini, S. Bonazzola, D. Macconi, R. Maucci, F. Porrati, A. Benigni, C. Picciolo, and G. Remuzzi. 2004. L-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant species. Hypertension 43: 614-622.
39. Cavinato, R. A., F. Casiraghi, N. Azzollini, M. Mister, A. Pezzotta, P. Cassis, D. Cugini, N. Perico, G. Remuzzi, and M. Noris. 2007. Role of thymic- and graft-dependent mechanisms in tolerance induction to rat kidney transplant by donor PBMC infusion. Kidney Int. 71: 1132-1141.
40. Meng, L., Z. Wu, Y. Wang, C. Lassman, R. W. Busuttil, Y. Zhai, and J. W. Kupiec-Weglinski. 2008. Differential impact of CD154 costimulation blockade on alloreactive effector and regulatory T cells in murine renal transplant recipients. Transplantation 85: 1332-1338.
41. Schaefer, L., A. Babelova, E. Kiss, H. J. Hausser, M. Baliova, M. Krzyzankova, G. Marsche, M. F. Young, D. Mihalik, M. Gotte, et al. 2005. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J. Clin. Invest. 115: 2223-2233.
42. Tesar, B. M., D. Jiang, J. Liang, S. M. Palmer, P. W. Noble, and D. R. Goldstein. 2006. The role of hyaluronan degradation products as innate alloimmune agonists. Am. J. Transplant. 6: 2622-2635.
43. Radi, R., J. S. Beckman, K. M. Bush, and B. A. Freeman. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288: 481-487.
44. + interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int. 70: 591-596.
45. + dendritic cells evoking Th1 and Th17 responses. J. Immunol. 179: 1449-1457.
46. Warger, T., P. Osterloh, G. Rechtsteiner, M. Fassbender, V. Heib, B. Schmid, E. Schmitt, H. Schild, and M. P. Radsak. 2006. Synergistic activation of dendritic cells by combined Toll-like receptor ligation induces superior CTL responses in vivo. Blood 108: 544-550.
47. Cisco, R. M., Z. Abdel-Wahab, J. Dannull, S. Nair, D. S. Tyler, E. Gilboa, J. Vieweg, Y. Daaka, and S. K. Pruitt. 2004. Induction of human dendritic cell maturation using transfection with RNA encoding a dominant positive Toll-like receptor 4. J. Immunol. 172: 7162-7168.
48. + T cells. Immunology 122: 149-156.
49. + T cell-mediated suppression by dendritic cells. Science 299: 1033-1036.
50. Chen, X., O. M. Howard, and J. J. Oppenheim. 2007. Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J. Immunol. 178: 6123-6129. (Pubitemid 46717393)
51. Li, W., K. Carper, Y. Liang, X. X. Zheng, C. S. Kuhr, J. D. Reyes, D. L. Perkins, A. W. Thomson, and J. D. Perkins. 2006. Anti-CD25 mAb administration prevents spontaneous liver transplant tolerance. Transplant. Proc. 38: 3207-3208. (Pubitemid 44908478)
52. + T cell responses to herpes simplex virus type 2 in neonatal mice. J. Immunol. 180: 1556-1564.
53. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
54. Zhou, L., I. I. Ivanov, R. Spolski, R. Min, K. Shenderov, T. Egawa, D. E. Levy, W. J. Leonard, and D. R. Littman. 2007. IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8: 967-974. (Pubitemid 47300011)
55. Degauque, N., C. Mariat, J. Kenny, D. Zhang, W. Gao, M. D. Vu, S. Alexopoulos, M. Oukka, D. T. Umetsu, R. H. DeKruyff, et al. 2008. Immunostimulatory Tim-1-specific antibody deprograms Tregs and prevents transplant tolerance in mice. J. Clin. Invest. 118: 735-741.
56. Mitchell, P., B. Afzali, G. Lombardi, and R. I. Lechler. 2009. The T helper 17-regulatory T cell axis in transplant rejection and tolerance. Curr. Opin. Organ Transplant. 14: 326-331.
57. Porrett, P. M., X. Yuan, D. F. LaRosa, P. T. Walsh, J. Yang, W. Gao, P. Li, J. Zhang, J. M. Ansari, W. W. Hancock, et al. 2008. Mechanisms underlying blockade of allograft acceptance by TLR ligands. J. Immunol. 181: 1692-1699.
58. Bozza, S., T. Zelante, S. Moretti, P. Bonifazi, A. Deluca, C. D'Angelo, G. Giovannini, C. Garlanda, L. Boon, F. Bistoni, et al. 2008. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J. Immunol. 180: 4022-4031.
59. Ueno, H., E. Klechevsky, R. Morita, C. Aspord, T. Cao, T. Matsui, T. Di Pucchio, J. Connolly, J. W. Fay, V. Pascual, et al. 2007. Dendritic cell subsets in health and disease. Immunol. Rev. 219: 118-142.
60. Kim, Y. S., S. H. Yang, H. G. Kang, E. Y. Seong, S. H. Lee, W. Gao, J. Kenny, X. X. Zheng, and T. B. Strom. 2006. Distinctive role of donor strain immature dendritic cells in the creation of allograft tolerance. Int. Immunol. 18: 1771-1777.
61. + regulatory T cells from peripheral Foxp3 precursors. Blood 110: 4293-4302.
62. Liang, Y., K. Christopher, P. W. Finn, Y. L. Colson, and D. L. Perkins. 2007. Graft produced interleukin-6 functions as a danger signal and promotes rejection after transplantation. Transplantation 84: 771-777.
63. Kouwenhoven, E. A., R. W. de Bruin, I. M. Bajema, R. L. Marquet, and J. N. Ijzermans. 2001. Cold ischemia augments allogeneic-mediated injury in rat kidney allografts. Kidney Int. 59: 1142-1148.
64. Tsuboi, N., Y. Yoshikai, S. Matsuo, T. Kikuchi, K. Iwami, Y. Nagai, O. Takeuchi, S. Akira, and T. Matsuguchi. 2002. Roles of Toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J. Immunol. 169: 2026-2033.